The purpose of this protocol is to retrospectively study the influence of age at start of growth hormone (GH) treatment on height gain in children born small for gestational age (SGA).
- SGA children.
- Treated with GH at least 36 months.
- Patients treated with GH for other indications (not SGA).
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: